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Abstract 
 The objectives of this study were to measure the incidence and types of medication prescribing errors (MPEs) in Iraqi hospitals, to 
calculate for the first time the percentage of physician agreement with pharmacist medication regimen review (MRR) 
recommendations regarding MPEs, and to identify the factors influencing the physician agreement rate with these recommendations.  
Methods: Fourteen pharmacists (10 females and 4 males) reviewed each hand-written physician order for 1506 patients who were 
admitted to two public hospitals in Al-Najaf, Iraq during August 2015. The pharmacists identified medication prescribing errors using 
the Medscape WebMD, LCC phone application as a reference. The pharmacists contacted the physicians (2 females and 34 males) in-
person to address MPEs that were identified. Results: The pharmacists identified 78 physician orders containing 99 MPEs with an 
incidence of 6.57 percent of all the physician orders reviewed. The patients with MPEs were taking 4.8 medications on average. The 
MPEs included drug-drug interactions (65.7%), incorrect doses (16.2%), unnecessary medications (8.1%), contra-indications (7.1%), 
incorrect drug duration (2%), and untreated conditions (1%). The physicians implemented 37 (37.4%) pharmacist recommendations. 
Three factors were significantly related to physician acceptance of pharmacist recommendations. These were physician specialty, 
pharmacist gender, and patient gender. Pediatricians were less likely (OR= 0.1) to accept pharmacist recommendations compared to 
internal medicine physicians. Male pharmacists received more positive responses from physicians (OR=7.11) than female pharmacists. 
Lastly, the recommendations were significantly more likely to be accepted (OR= 3.72) when the patients were females. Conclusions: 
The incidence of MPEs is higher in Iraqi hospitalized patients than in the U.S. and U.K, but lower than in Brazil, Ethiopia, India, and 
Croatia. Drug-drug interactions were the most common type of MPEs in hospitals. Physician specialty and pharmacist gender and 
patient gender significantly influenced physician agreement with the pharmacist comments. Only one-third of the pharmacist 
recommendations were implemented. Phone drug applications would be helpful for daily hospital pharmacy practice. More 
pharmacist-physician collaboration is needed to address MPEs. Pharmacist-led MRR can identify and address MPEs to improve patient 
safety. 
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Introduction 
Healthcare scholars classify medication errors into four 
categories: those physicians make during prescribing, those 
pharmacists make during dispensing, those nurses or patients 
make during administration, and those, which occur during 
monitoring. Prescribing error is “‘a failure in the prescribing 
process that leads to, or has the potential to lead to, harm to 
the patient’ (Aronson, 2009) [1]. Prescribing errors are  
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preventable events which include incorrect dose, incorrect 
duration, unnecessary medications, contraindications or 
interactions [2-4].  
 
Patients with medication prescribing errors (MPEs) are at risk 
for significant medication-related problems (MRPs) which 
include adverse drug events (ADEs) and harmful drug 
interactions.  Adverse drug events (ADEs) are injuries due to 
adverse drug reactions or medication errors [4]. Adverse drug 
reactions are considered non-preventable while medication 
errors are considered preventable ADEs. Drug interactions 
include drug-drug, drug-food and drug-disease interactions 
and all of these can increase or decrease a drug’s activity or 
aggravate another disease. 
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Simonson and colleagues report that MRPs contribute to 
approximately  200,000 deaths in the U.S. annually [5].  A 
one-year study in a teaching hospital in New York, USA 
identified and addressed 2103 prescribing errors [6]. One 
study of a teaching hospital in the U.S. identified 1.9% 
prescribing errors. During the 6-month study, the pharmacist 
prevented 479 medication errors in two pediatric hospitals 
[7]. In a 4-week period study in a British hospital, pharmacists 
reported 651 MPEs [8]. Systematic reviews have showed 
polypharmacy—concurrent use of multiple medications— is 
directly related to drug-drug interaction, ADEs and 
hospitalization [2, 9]. Pharmacists are often the last line of 
defense against physician prescribing errors. Many 
pharmacists assume identifying physician prescribing errors is 
enough to prevent patient harm. Despite this important role, 
pharmacists have no authority to change medication 
regimens without prescriber (physician) permission. Thus, 
pharmacists need to work with physicians to address errors. 
This study investigated the factors influencing physician 
acceptance of pharmacist recommendations.  
      
Pharmacist-led medication regimen review (MRR) is an 
evaluation of patient drug regimens to prevent, identify, 
report, and resolve any MRPs such as medication errors, 
drug-contraindications, interactions, and inappropriate 
polypharmacy (unnecessary multiple medications) [10]. The 
MRR  has been shown to lower the rates of medication errors 
, MPEs  and other ADEs [11, 12]. Three randomized controlled 
trials found that pharmacist-led MRR significantly lowered 
drug-related problems and the number of repeated 
prescriptions among elderly patients above 65 years of age 
[13-15]. Additionally, a recent systematic review and meta-
analysis of twenty one studies concluded that pharmacist-led 
MRR significantly improved subjects’ blood pressure and lipid 
levels (low density lipoprotein) [16]. Consequently, MRR 
enhances medication safety and reduces hospitalization.  
 
Pharmacists are the most competent health care providers to 
conduct a MRR because they have knowledge and experience 
in pharmacology, pharmacokinetics, pharmacodynamics, and 
pharmacy systems [12]. Pharmacists can access various 
medical data sources such as laboratory reports and patient 
medical records in addition to communicating with other 
health care providers [12]. A pharmacist conducts MRR to 
ensure that dosage levels are appropriate (neither over- nor 
under-dose), that all medications are necessary (supported by 
appropriate diagnosis), the patients are not allergic to 
prescribed medications, and there are no significant drug-
drug or drug-disease interactions [10].  
 
Several factors may influence effectiveness of pharmacist-led 
MRR and the degree of prescriber acceptance of pharmacist 
recommendations including medical ward, the individual 
characteristics, specialty and years of experience of both 
pharmacist and prescriber (physicians). 
 
In 2013, a systematic review of medication errors in Middle 
Eastern countries found no study investigating this critical 
topic in Iraq [17]. There was only one Iraqi study measuring 
medication errors by 2014 and this was an observational 
study (without interventions) which evaluated the types and 
medication classes of these errors [18]. Although several 
studies have investigated pharmacist interventions in 
prescribing errors around the world [6, 8, 19-25], almost all of 
these studies were limited to evaluations of the incidence 
rate, causes, clinical significance and types of prescribing 
errors. However, a little is known about physician acceptance 
rate of pharmacist recommendations and only a couple of 
studies have focused on implementation of 
recommendations [26, 27]. None of the previous prescribing 
error studies in hospitals (to our knowledge) investigated 
factors influencing physician agreement with pharmacist 
recommendations. Almost all the previous studies that 
investigated pharmacist interventions in prescribing errors 
have used conventional medication review to find the 
medication errors. In our study, hospital pharmacists 
identified medication prescribing errors using the Medscape 
WebMD, LCC phone application as a reference. Additionally, 
our study is the first to investigate pharmacist interventions 
to address prescribing errors in Iraq.  
 
The objectives of this study were to measure the incidence 
and types of MPEs in Iraqi hospitals, to calculate the 
percentage of physician agreement with pharmacist 
medication regimen review recommendations regarding 
medication prescribing errors (MPEs), and to identify for the 
first time the factors influencing the physician agreement 
rate. 
 
Methods 
This study was an interventional prospective study.  Fourteen 
pharmacists (10 females and 4 males) prospectively reviewed 
1506 hand-written physician medication orders for inpatients 
in two public teaching hospitals in Al-Najaf Province, Iraq 
during August 2015. The pharmacists had a mean age of 
26.86 (±2.54) years and mean time of practice of 1.5 (±1.3) 
years. Eight of the pharmacists (four males and four females) 
were hospital employees and had the authority to contact the 
prescribers (physicians).The other six female pharmacists 
were college of pharmacy affiliated pharmacists - who helped 
the hospital pharmacists in MRR. The physicians’ mean age 
was 50.5 (± 9.69) years.  
The sampling included physician orders for every patient 
admitted into three wards during the month of the study 
(census sampling). These three wards were distributed 
between two teaching hospitals: one had surgery and internal 
medicine wards (80 beds), and the other had four pediatric 
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wards (160 beds).  The internal medicine ward contained a 
cardiology section while the surgery ward included general-
surgery, thoracic-surgery, neuro-surgery and orthopedic-
surgery.  
 
The pharmacists identified MPEs using the Medscape 
WebMD, LCC phone application as a reference[28]. The MPEs 
included inappropriate doses, inappropriate treatment 
duration, contraindications, significant drug-drug 
interactions, untreated conditions, and unnecessary 
medications. Because the physician order was updated on a 
daily basis, the pharmacists reviewed physician orders, which 
had no MPEs twice, on two consecutive days. However, no 
changes were made to physician orders and no MPEs were 
found on the second day of the reviewing. To confirm the 
error, any order with MPEs was reviewed by two pharmacists.  
After the pharmacists identified MPEs and reported the type 
of error, they contacted (face-to-face) the prescriber 
(physician) to address the problems. Pharmacists reported 
whether the physicians accepted their recommendations or 
not and whether the MPEs addressed or not. Physician and 
pharmacist characteristics were also reported such as age, 
gender, specialty, and years of practice. Additionally, the 
pharmacist recorded the medical wards and the demographic 
data of the patients with the MPEs including age, gender in 
addition to the names of current medications (with doses, 
frequency and duration), and the number of days in the 
hospital. The study received permission from the Iraqi 
Universities and an exemption from the University of Iowa 
Institutional Review Board. 
 
Statistical Analyses 
The analyses were conducted using Statistical Analysis System 
(SAS, version 9.3, SAS Inc., Cary, North Carolina, USA). Means, 
range, and standard deviation (SD), frequencies and 
percentages of participant characteristics, such as 
pharmacists and physicians’ age, gender, practice years and 
specialty, were calculated. Patients’ age, gender, number of 
hospitalization days, and medications were also recorded. A 
binary logistic regression analysis was conducted to measure 
the association between the independent variables (ward, 
physician, pharmacist and patient characteristics), and the 
binary outcome variable (physician implementation of 
pharmacist recommendations: Yes/NO). The logistic 
regression analysis was conducted for the 78 independent 
medication orders with MPEs because the physicians who 
agreed with pharmacist recommendations about 21 orders 
addressed all 37 errors in these records at once. Bivariate 
regression analyses were conducted to reduce the number of 
independent variables included in the multivariate model and 
only those which were significant at 0.20 or better (p-value ≤ 
0.20 ) such as ward, physician-experience year, pharmacist-
gender, and patient-gender were included in the final 
regression model. Severity and types of the MPEs were also 
calculated. The figures were plotted using GraphPad Prism 6 
software (San Diego California USA, www.graphpad.com). 
 
Results 
The pharmacists identified 78 physician orders with at least 
one prescribing error for a total of 99 errors and an incidence 
of 6.57 percent. The eight hospital pharmacists informed 36 
physicians (2 females and 34 males) in-person about MPEs 
and nine of them were contacted more than once. The 
female pharmacists contacted physicians about 63 physician 
orders while the male pharmacists informed the physicians 
about 15 erroneous orders. The physician orders with MPEs 
had 4.80 (±2.1) medications on average not including 
intravenous fluids (glucose saline, Ringer’s solution and 
normal saline) and oxygen. When the intravenous fluids were 
included, the patients with MPEs had an average of 5.06 
(±2.1) medications.  The 99 MPEs were found for 78 different 
patients (41 male and 37 female) with a mean age of 27.82 
(±27.4) years (table-1). The pediatric, internal medicine and 
surgery wards had 43 (43.4%), 29 (29.3%), and 27 (27.3%) 
MPEs respectively. More than half the patients (51.3%) with 
MPEs were less than 18 years old (Table 1). 
 
The pharmacists identified six different types of the MPEs 
(figure 1). Drug-drug interactions were the most common 
type (65.7%) while untreated conditions were the least 
common type (1.0%) of MPE (Figure 1). Drug 
contraindications included prescribing tramadol (opioid 
derivative) for patients less than 16 years old and mefenamic 
acid (non-steroidal anti-inflammatory drug, NSAID) for 
patients less than 14 years old. Incorrect doses included 
prescribing full regular doses for patients with renal or 
hepatic failure when the doses needed to be reduced (Table 
2). Narrow therapeutic index drugs were found 37 times with 
MPEs including vancomycin (n= 9), amikacin (7), 
aminophylline (n=6), phenobarbital (n=6), phenytoin (n=3), 
digoxin (n=2), gentamycin (n=2) and valproate (n=1), and 
carbamazepine (n=1).  Systemic antibiotics (28.3%) and 
cardiovascular medications (17.2%) were the most common 
medication categories involved in the MPEs (Figure 2). The 
majority of the MPEs were clinically significant (72.7%) and 19 
(19.2%) of them were serious errors (Table 2). 
The physicians implemented only 37 (37.4%) pharmacist 
recommendations (19 for male pharmacists and 18 for female 
pharmacists) to address these MPEs. The logistic analysis 
results showed that three factors were significantly 
associated with the outcome variable (physician 
implementation of pharmacist recommendations). 
Pediatricians were less likely (Odds Ratio (OR)= 0.10; 95% 
Confidence Interval (CI)= 0.01-0.73) to accept  pharmacist 
recommendations compared to internal medicine physicians. 
The physicians were seven times more likely (OR=7.1; 95% 
CI=1.1-45.4) to respond positively to male pharmacists than 
female. Lastly, physicians had significantly more positive (OR= 
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3.7; 95% CI= 1.07-12.95) responses when the patients were 
female (Table-2).  
 
Male pharmacists had no recommendations about minor 
errors while 11.27% of female pharmacists’ 
recommendations were about minor errors. On the other 
hand, 25 % of male pharmacists’ recommendations were 
about serious/fatal errors and 75% about significant errors 
whereas 16.9% and 71.83% of female pharmacists’ 
recommendations were about serious and significant errors 
respectively.   
 
Discussion 
The pharmacists were younger and they had spent fewer 
years in practice than the physicians (Table 1). This may 
explain the low response rate of physicians to pharmacist 
recommendations. Half of the patients with MPEs were 
children because one of the two hospitals was a pediatric 
hospital. Two thirds of the MPEs were drug-drug interactions, 
which the physicians may not consider significant errors 
although some of them had potential serious consequences 
(Table 2). Only six (9.7%) of the rejected recommendations 
were about non-significant (minor) errors while 14 (22.6%) of 
them were about potentially serious errors. Taking multiple 
concurrent medications was probably reason for higher 
interaction errors.  
 
Although the Iraqi physicians had about 10 times as many 
years of experience as the pharmacists, they committed 
relatively high prescribing error rates, which may be due to 
outdated pharmacotherapeutics knowledge. The lack of an 
electronic health record (EHR) in Iraqi hospitals may 
negatively influence prescribing practices because physicians 
may not have a full patient medical/ medication history in a 
paper chart, particularly if a patient has been admitted 
multiple times.  
Our study found that the incidence of MPEs in the two Iraqi 
hospitals (6.6 %) was at least three times higher than in the 
U.S. (0.3-1.9%) and U.K (1.5%) [7, 8, 25]. A one-year study in a 
teaching hospital in NY, USA, found 0.399% prescribing 
errors[6]. A study of an internal medicine clinic in a university 
hospital in Zagreb, Croatia had higher incidence of MPEs 
(7.7%) than Iraqi hospitals [21]. Other countries had much 
higher MPE incidence rate. For example, Brazilian intensive 
care unit had 43.5 % MPEs, and Ethiopian, Saudi and Indian 
hospitals had 40 %, 56% and 34 % MPEs respectively [20, 22, 
24, 29].  
Two-third (65.7%) of the MPEs in this study were drug-drug 
interactions and 9.2%, 67.7% and 23.1% of them were minor, 
significant and serious interactions respectively. The number 
and types of medications used may have contributed to the 
high percentage of drug-drug interactions. In the pediatric 
hospital, 11 out of 43 children were treated for epilepsy or a 
febrile fit using phenytoin, phenobarbital, carbamazepine, 
valproate, and/ or clonazepam which are narrow therapeutic 
index medications and highly susceptible to drug-drug 
interactions particularly with antibiotics. Our study findings 
agree with an Indian study showing drug-drug interactions 
were the most common prescribing error in teaching 
hospitals (65.7% and 68.2% respectively) and antibiotics were 
the most frequent medication category  associated with 
prescribing errors (28.3.3% and 29.4% respectively)[24].  
Similarly, a  study in Croatia found that drug-drug interactions 
were the most common error type and accounted for 14.7 
percent of prescribing errors[21]. However, British, American 
and Saudi studies reported that incorrect dose was the most 
common prescribing error (54%, 39.7% and 22.1% 
respectively) [6, 8, 29]. Similarly, a 14-day study in teaching 
hospitals in Netherlands indicated the dosing errors 
(dose/duration) was the most common prescribing error type 
(63%) [19]. Therefore, among the reviewed studies in the 
literature, our study had the second highest percentage of 
drug-drug interaction errors. 
 
This study identified systemic antibiotics as the most frequent 
therapeutic category were involved in all prescribing errors 
(28.3%). That suggests physicians chose antibiotic(s) without 
considering their interactions with chronic disease 
medications. Surgical and pediatric ward patients usually 
receive antibiotics either as post-operative prophylaxis or to 
treat systemic infections. The observational Iraqi study (in the 
Kurdistan region) also found that antibiotics were the most 
common therapeutic category associated with medication 
errors (32.4 %) in a pediatric hospital[18]. Likewise, the 
Brazilian (45.7%)  and American (23.1%) studies found 
systemic antibiotics were the most frequent medication 
category involved in MPEs in neonates[22, 25].  In the Dutch 
study, central nervous system medications were the most 
commonly involved in prescribing errors[19]. Thus, this study 
confirmed the findings of studies from around the world that 
antibiotics are the most common medication category 
involved in prescribing errors [22, 24, 25]. 
 
The low physician acceptance of pharmacist 
recommendations suggests that physicians may 
underestimate the risk of drug-drug interactions. In fact, 
some of these interactions were categorized as serious 
errors. For instance, interactions of ceftriaxone with heparin, 
warfarin or ringer solution can have serious or even fatal risks 
for patients (Table 2). There were no hospital regulations 
requiring physicians’ response to pharmacist 
recommendations. The difference between the physicians’ 
and pharmacists’ experience may also have contributed to 
the low physicians’ acceptance rate of pharmacist 
recommendations. Physicians may consider the benefits of 
certain medications outweigh their risks. In contrast, a study 
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in a pediatric and obstetric hospital in Spain found that the 
physician acceptance of pharmacist recommendations was 
three times (92.2%) higher than in Iraq [27].  
 
In this study, the physicians who agreed with the pharmacist 
implemented the recommendations. Hence, the pharmacists 
helped to avert 37 MPEs. The pediatricians were less likely to 
agree with pharmacist recommendations because they may 
have a smaller available list of medications compared to 
internal medicine physicians. Thus, the pediatricians may not 
believe they need pharmacist recommendations. The 
physicians were more likely to implement the 
recommendations of male pharmacists which may be due to 
the fact that male physicians (96.8%) have stronger 
collaborative relationships with male pharmacists than 
females because of the strong gender barrier in this 
conservative city. A Canadian study found a gender bias 
among orthopedic surgeons when they referred and 
recommended total joint arthroplasty [30]. Hence, gender 
bias behavior cannot be excluded. Finally, because male 
pharmacists focused only on significant and serious MPEs, 
this may play a role to receive three times higher 
recommendation-acceptance rate from physician compared 
to female pharmacists. 
 
The patients with MPEs had not been informed about the 
errors to avoid any patient-physician conflicts. The results 
showed the physicians significantly more accepted 
pharmacist recommendations when the patients were 
female. This result has no clear explanation because the 
patients were not involved in the pharmacist-physician 
communications.  
 
There are two types of pharmacists working in Iraqi hospitals: 
General pharmacists who work in a main pharmacy to supply 
medications and maintain stock and clinical pharmacists who 
work in clinical wards [31]. The hospital pharmacists who 
participated in the study were clinical pharmacists and those 
passed a credential exam in clinical fields after their 
graduation.  The duties of clinical pharmacists include 
reviewing medication regimens to minimize inappropriate 
prescribed medications, distributing medications to 
inpatients and counseling inpatients, caregivers and/or 
nurses about medication administrations [31]. However, 
there is no official quality auditing on pharmacist-led MRR 
and it is totally up to pharmacist to conduct a thorough or 
suboptimal reviewing because physicians are usually 
responsible for any prescribing errors.  Thus, hospitals need 
to impose incentives and regulations encouraging 
pharmacists to review physician orders effectively to 
minimize prescribing errors. Furthermore, Iraqi Ministry of 
Health should issue regulations urging physicians to address 
pharmacists’ recommendations.   
 
Iraqi hospital pharmacists and physicians should have the 
same medication error checking references to avoid 
disagreement about the safety of prescribed medications. 
Hospitals can hold workshops and seminars to increase 
awareness of prescriber error incidence and negative 
consequences. Healthcare providers should also exert more 
efforts to enhance their collaboration to eliminate the 
incidence of MPEs. 
 
Limitations 
This study was conducted for one month in one province. 
However, it involved three different medical wards in 
standard Iraqi governmental hospitals with a typical degree of 
pharmacist-physician collaboration. The study included public 
hospitals only because private hospitals have no hospital 
pharmacists. 
 
Conclusions and Recommendations 
Iraqi hospitalized patients with multiple medications 
experience a greater number of MPEs than patients in the 
U.K and U.S., but fewer than patients in Brazil, Saudi Arabia, 
Ethiopia and Croatia. Drug-drug interactions were the most 
common MPEs found in this study. Antibiotics and 
cardiovascular medications were the most frequent 
therapeutic categories associated with prescribing errors. 
Only one-third of the physicians complied with the 
pharmacist recommendations. Medical ward, pharmacist 
gender, and patient gender significantly influence physician 
implementation of pharmacist recommendations. 
Implementing EHR can enhance medication prescribing 
appropriateness. Phone drug applications would be helpful 
for daily hospital pharmacy practice. Pharmacist-led MRR can 
identify and address MPEs to improve patient safety.  
Fostering pharmacist-physician collaboration may increase 
physician acceptance rate of pharmacist recommendations. 
Pharmacists should review every single medication regimen 
before dispensing medications to minimize prescribing errors 
and patient harm and enhance patient health outcome. 
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Table 1: Physician, pharmacist and patient with prescribing error characteristics 
Characteristic Mean ST.DV Minimum Maximum 
Physician age (years) 50.5 9.7 33 78 
Physician practice years 16.9 8.6 1.0 40 
Patient hospital days of stay 4.0 3.7 1.0 20 
Child-Patient (N=40) age (years) 4.47 4.27 0.3 14 
Adult-patient (N=38) age (years) 52.4 18.32 20 80 
Number of patient Medications 4.8 2.1 1.0 10 
Pharmacist age (years) 26.9 2.5 25 34 
Pharmacist practice years 1.5 1.3 0.3 5.0 
 
* ST.DV= standard deviation, number of physicians=36, number of pharmacists=14 and number of  
patients with medication prescribing errors=78.  
 
 
 
 
 
 
 
Figure 1: Percentages and frequencies of medication prescribing error types 
 
6 5 .6 6 %   D ru g -d ru g  in te ra c t io n
1 6 .1 6 %   In c o rre c t d o s e
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7 .0 7 %   C o n tra in d ic a tio n
2 .0 2 %   In c o rre c t d u ra t io n
1 .0 1 %   U n tre a te d  c o n d itio n
 
 
Contraindication means drug should not be used for patient because it is harmful such as  
prescribe mefenamic acid for patients with less than 14 years old. Incorrect duration means  
using treatment for longer or shorter period than that mentioned in the reference. 
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Figure 2: The frequencies of therapeutic categories involved in the prescribing errors 
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*Multiple drug-categories’ interactions include: 6 systemic antibiotics with cardiovascular (CVD) medications, 6 systemic antibiotics with central 
nervous system (CNS) medications, 1 systemic antibiotic with respiratory medications, 1 CNS with respiratory medication. COPD= Chronic 
Obstructive Pulmonary Diseases (Chronic bronchitis or Emphysema) medications include systemic bronchodilators (salbutamol and aminophylline), 
and corticosteroids (hydrocortisone and dexamethasone) ; NSAID=Non-Steroidal Anti-inflammatory Drug (Mefenamic acid); GIT (Gatro-Intestinal 
Tract) Ulcer = H2-blocker (Ranitidin) or Proton Pump Inhibitor (Omeprazole); I.V. fluid = Intravenous fluid (Glucose Saline) is given to patient with 
uncontrolled Diabetes Mellitus.  
 
 
Table 2: Frequency and examples about three levels of prescribing error severity 
 
Prescribing error 
 severity degree 
N (%) 
 
Example 
Minor 1 8 (8.1) • Prescribing ranitidine and opemrazole concurrently to patients 
without GIT ulcer. 
• Interaction between Phenobarbital- phenytoin 4 
 
Significant 2 72 (72.7) • Prescribing  tramadol to patients less than 16 year- old 5 
• Prescribing mefenamic acid to patients less than 14 year-old. 
• No meropenem dose adjustment in patients with renal 
impairment (Creatinine Clearance=14 ml/min). 
• No metronidazole dose adjustment in patients with hepatic 
impairment. 
• Prescribing overdoses of oral salbutamol for children. 
Serious 3 19 (19.2) • Interaction between ceftriaxone- warfarin 6. 
• Interaction between ceftriaxone- heparin. 
• Prescribing Glucose Saline fluid to a diabetic child with 
Random Blood Glucose= 654mg/dl. 
• Interaction between ceftriaxone and ringer intravenous 
solution (Calcium gluconate)7. 
1 Minor error has non-significant/potential inconvenient for patients. 2 Significant error has potential significant risk/ injury for patients. 3 
Serious error has potential serious/fatal risk for patients.4 “Phenobarbital decreases levels of phenytoin by increasing metabolism. Minor 
or non-significant interaction”.  5 Severe respiratory depression reported with off-label use of tramadol in children. 6 “ceftriaxone 
increases effects of warfarin by anticoagulation. Possible serious or life-threatening interaction. Monitor closely”. 7 “Do not use any 
calcium-containing solutions (including Ringer's) in combination with IV ceftriaxone; risk of potentially fatal particulate precipitation in 
lungs, kidneys. Separate by at least 48 hrs”[28].  
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Table-3: Logistic regression results: Factor influencing physician 
response to pharmacistdrug recommendations 
 
Independent Variable Odds Ratio  
Estimate 
(OR) 
95% Wald 
Confidence Limits 
P-value 
Ward /  
Pediatrics vs Internal Medicine 
0.10 0.01 0.73 0.02* 
 
Ward  / 
 Surgery vs Internal Medicine 
 
 
2.89 
 
0.67 
 
12.41 
 
0.15 
Physician-experience years 1.06 0.98 1.15 0.13 
Pharmacist-gender/  
male vs female 
7.11 1.11 45.44 0.04* 
Patient-gender/   
 female vs male 
3.72 1.07 12.95   0.04* 
          *statistically significant (P≤ 0.05); Outcome variable (physician implementation of pharmacist  
            recommendations ): Yes vs NO. Number of orders had MPEs (N)=78. 
 
 
 
 
 
 
 
 
